HLA DR1/3/4/5, DQ Intermediate Resolution

Last Modified: 11/20/2019 7:27:17 AM


Specimen Requirements: 7.0 mL Whole Blood from two (2) Lavender Top Tubes
Transport & Storage: Temperature/Stability: Ambient

Protect from Extreme heat or cold

Do not Freeze
Rejection Criteria: Hemolyzed specimen; clotted specimen; wrong specimen container
Reference Range: Refer to Interpretive Results
Methodology: Sequence-based typing (SBT), sequence oligonucleotide probes (SSOP), and/or sequence-specific primer
Clinical Significance: HLA antigens may be correlated with certain disease states or other clinical conditions. Indicate in clinical information which antigen(s) is of interest. Also used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.
Documentation: Limitations: This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 3 to 7 days
Sites Performed: Lab Corp
PHL Test Code: MSOT
EPIC Test Code: MISC
Send Out Test Code: 167120
CPT Coding: 81375

Go back to the top of the page.